CATALOGO DEI PRODOTTI DELLA RICERCA

DE MANZONI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.149
EU - Europa 12.404
AS - Asia 8.941
SA - Sud America 1.180
AF - Africa 359
Continente sconosciuto - Info sul continente non disponibili 351
OC - Oceania 35
AN - Antartide 1
Totale 36.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.869
RU - Federazione Russa 4.715
SG - Singapore 3.687
GB - Regno Unito 2.785
CN - Cina 2.533
IT - Italia 1.322
BR - Brasile 948
HK - Hong Kong 784
VN - Vietnam 744
DE - Germania 652
SE - Svezia 648
FR - Francia 610
IE - Irlanda 583
FI - Finlandia 454
KR - Corea 314
UA - Ucraina 174
BD - Bangladesh 154
CA - Canada 135
TR - Turchia 128
JP - Giappone 115
IN - India 102
NL - Olanda 89
NG - Nigeria 81
ES - Italia 77
MX - Messico 77
AR - Argentina 75
IQ - Iraq 60
AT - Austria 55
ZA - Sudafrica 55
ID - Indonesia 54
TG - Togo 48
PL - Polonia 44
BE - Belgio 40
BJ - Benin 38
EC - Ecuador 38
AU - Australia 31
UZ - Uzbekistan 31
CO - Colombia 29
PK - Pakistan 29
PY - Paraguay 28
CZ - Repubblica Ceca 22
RW - Ruanda 22
EG - Egitto 21
JO - Giordania 21
LT - Lituania 21
IL - Israele 20
AE - Emirati Arabi Uniti 18
CL - Cile 18
SA - Arabia Saudita 18
KE - Kenya 17
PH - Filippine 17
VE - Venezuela 17
IR - Iran 16
MA - Marocco 15
KG - Kirghizistan 14
NO - Norvegia 14
DZ - Algeria 12
PT - Portogallo 12
UY - Uruguay 12
MY - Malesia 11
PA - Panama 11
TN - Tunisia 11
GR - Grecia 10
PE - Perù 10
AL - Albania 9
EU - Europa 9
JM - Giamaica 9
LV - Lettonia 9
HN - Honduras 8
AO - Angola 7
BG - Bulgaria 7
CR - Costa Rica 7
ET - Etiopia 7
KZ - Kazakistan 7
OM - Oman 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
AZ - Azerbaigian 6
CH - Svizzera 6
DO - Repubblica Dominicana 6
RO - Romania 6
BY - Bielorussia 5
LB - Libano 5
SN - Senegal 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
AM - Armenia 4
BH - Bahrain 4
GE - Georgia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
MK - Macedonia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
RS - Serbia 4
SI - Slovenia 4
SV - El Salvador 4
BO - Bolivia 3
BZ - Belize 3
Totale 36.018
Salva come PNG Salva come JPEG
Città #
Southend 2.395
Singapore 1.953
Moscow 1.511
Ashburn 1.471
San Jose 1.300
Jacksonville 1.158
Chandler 1.142
Dallas 988
Hong Kong 776
Woodbridge 699
Verona 673
Dublin 578
Ann Arbor 460
Beijing 444
The Dalles 408
Houston 323
New York 309
Council Bluffs 287
Ho Chi Minh City 273
Los Angeles 245
Lawrence 204
Princeton 204
Wilmington 199
Jinan 182
Hanoi 164
Nanjing 157
Munich 141
Shenyang 140
Redmond 132
Buffalo 121
Milan 114
Helsinki 111
Tokyo 102
Hebei 100
Sindelfingen 97
Santa Clara 96
São Paulo 91
London 84
Redondo Beach 80
Abuja 78
Columbus 77
Tianjin 74
Changsha 69
Nanchang 62
Seoul 60
Zhengzhou 60
Guangzhou 56
Haikou 56
Amsterdam 52
Orem 52
Seattle 52
Atlanta 49
Jiaxing 48
Lomé 48
Ningbo 47
Frankfurt am Main 46
Boardman 43
Chicago 42
Brooklyn 41
Montreal 41
Rome 41
Stockholm 41
Brussels 40
Taizhou 39
Cotonou 38
Denver 38
Hangzhou 38
Warsaw 37
San Francisco 36
Turku 36
Vienna 34
Nuremberg 33
Johannesburg 32
Rio de Janeiro 31
Dearborn 30
Toronto 30
Madrid 29
Mexico City 28
Norwalk 28
Baghdad 27
Phoenix 27
Tashkent 26
Boston 25
Chennai 24
Haiphong 24
Manchester 24
Lappeenranta 23
Washington 23
Ankara 22
Belo Horizonte 22
Jakarta 22
Kigali 22
Taiyuan 22
Curitiba 21
Dong Ket 21
Fuzhou 21
Paris 21
Poplar 21
Redwood City 21
Amman 20
Totale 22.203
Salva come PNG Salva come JPEG
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 317
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 297
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 287
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 267
Genomic characterization of hepatoid tumors: context matters 261
Segmental transverse colectomy. Minimally invasive versus open approach: results from a multicenter collaborative study 257
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 256
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 227
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 222
Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years 219
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 216
[Advanced gastric adenocarcinoma with RER+ phenotype presents a good prognosis after 5 years of curative resection] 211
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 208
Adenocarcinoma of the esophagogastric junction 208
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. 207
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 207
Valutazione dell’applicabilità del modello organizzativo della weeksurgery alle Chirurgia Generale di un Presidio di un’AziendaOspedaliera del Veneto 203
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 203
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 201
Acute hemorrhage secondary to gastric ulcer. Results of emergency endoscopic treatment in 775 cases. 199
hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications. 198
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 198
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 197
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 196
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 195
Enhanced recovery protocol in esophagectomy, is it really worth it? A cost analysis related to team experience and protocol compliance 194
Clinical pathways in gastric cancer care 194
Emergency sclerotherapy in esophageal and gastric acutely variceal bleeding : ten years expérience (1988-1997). 194
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients 191
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 188
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 188
Valutazione di uno screening colonscopico in pazienti ad alto rischio di CRC 185
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 183
Changing clinical and pathological features of gastric cancer over time. 182
Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. 181
Via biliare principale, pancreatite acuta e chirurgia mini-invasiva. 180
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 179
Textbook outcome following oesophagectomy for cancer: international cohort study 178
A new way to experience the International Gastric Cancer Association congress: the Web Round Tables 178
Short-term and long-term risk factors in gastric cancer 178
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 177
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 176
Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction 175
Lymphadenectomy for gastric cancer at European specialist centres 175
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 174
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 173
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 169
[Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up] 169
Endoscopic submucosal dissection in the treatment of gastric submucosal tumors: results from a retrospective cohort study. 169
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 169
Perianal Paget's disease: presentation of six cases and literature review. 168
Effectiveness of endoscopic vacuum therapy as rescue treatment in refractory leaks after gastro-esophageal surgery 168
Authors' reply: Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci (letter) 167
Experience on complex incisional hernia treatment in septic patients 166
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 164
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single centre study 164
[Patterns of transition between lymphangioma and intestinal lymphangiectasia. RAdiologic and histologic aspects of 2 cases with predominant involvement of the colon]. 162
Lack of an association between circulating adiponectin levels and risk of colorectal adenoma. 162
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 162
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 161
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 161
Factors influencing survival after hepatectomy for metastases from gastric cancer 161
Enhanced Recovery After Surgery can Improve Patient Outcomes and Reduce Hospital Cost of Gastrectomy for Cancer in the West: A Propensity-Score-Based Analysis 161
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 161
Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus 158
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 158
The value of in vitro ultrasonography in the intraoperative staging of gastric cancer. Blind study of 93 cases. 158
Perigastric lymph node metastasis in gastric cancer: comparison between different staging systems 157
Using the Angio-Seal to Achieve Hemostasis in Prosthetic Endovascular Surgery: Report of Three Cases 157
Complications after gastrectomy for cancer: Italian perspective 156
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 156
Western strategy for EGJ carcinoma 154
Biomarkers of myocardial infarction in patients undergoing gastrointestinal cancer surgery 153
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience 152
Management of critically ill surgical patients Case reports 152
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 151
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 150
Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study 150
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 150
Induction chemio-radiotherapy for squamous cell carcinoma of the thoracic esophagus: long-term results of a phase 2 study 149
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 149
Iatrogenic axillary artery injury from humeral neck fracture repair. A rare and unusual event in which and aggressive strategy was mandatory to save a child limb 149
Proximal Gastrectomy: Technical Notes 149
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 149
Effect of Pyloroplasty on Gastric Conduit Emptying and Patients' Quality of Life After Ivor Lewis Esophagectomy 149
Lymphadenectomy: how to do it? 148
Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer 148
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 147
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 147
Endosonography in esophageal cancer staging after preoperative chemo and radiotherapy. 145
Strengths and Limitations of the Evidence-Based Movement Aimed to Improve Clinical Outcomes in Dentistry and Oral Surgery 145
Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial 145
Lymphatic spread, lymph node stations, and levels of lymphatic dissection in gastric cancer 144
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma 144
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 143
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 143
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? 143
Induction chemo-radiotherapy for squamous cell carcinoma of the thoracic esofagus: impact of increased dosage on long-term results. 143
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 142
Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG) 141
Totale 17.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.952
article - articoli 115.871
book - libri 1.709
conference - conferenze 6.719
curatela - curatele 0
other - altro 681
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.972
Totale 257.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.427 0 382 37 129 83 39 40 111 53 53 121 379
2022/20233.544 242 310 327 622 297 867 14 255 384 27 88 111
2023/20242.015 58 167 170 254 219 321 108 110 25 121 351 111
2024/20255.515 295 333 273 846 267 183 400 291 747 453 417 1.010
2025/202615.612 1.093 746 971 2.510 3.896 1.121 1.574 897 1.242 885 302 375
2026/2027396 229 167 0 0 0 0 0 0 0 0 0 0
Totale 36.420